Page last updated: 2024-09-03

a 68930 and Cardiac Toxicity

a 68930 has been researched along with Cardiac Toxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jin, Y; Liu, J; Wang, B; Wang, Y; Zhang, J; Zuo, S	1

Other Studies

1 other study(ies) available for a 68930 and Cardiac Toxicity

Article	Year
Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome. Biochemical and biophysical research communications, 2021, 07-05, Volume: 561 Topics: Animals; Cardiotoxicity; Cells, Cultured; Chromans; Cytokines; Dopamine Agonists; Doxorubicin; Inflammasomes; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Dopamine D1; Signal Transduction; Topoisomerase II Inhibitors	2021

Article

Year

Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.

Biochemical and biophysical research communications, 2021, 07-05, Volume: 561

Topics: Animals; Cardiotoxicity; Cells, Cultured; Chromans; Cytokines; Dopamine Agonists; Doxorubicin; Inflammasomes; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Dopamine D1; Signal Transduction; Topoisomerase II Inhibitors

2021